HCA Healthcare, Inc.
HCA Healthcare, Inc.（HCA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · HCA · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
14
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
HCA Healthcare, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
HCA 季度内部人买卖趋势
HCA 内幕交易卖出 · HCA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · HCA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HCA 高管卖出股份 · HCA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 7, 2026 | Marks Mike A EVP and CFO | Gift | 3,336 | — | Form 4 |
| May 7, 2026 | Marks Mike A EVP and CFO | Gift | 3,336 | — | Form 4 |
| Apr 28, 2026 | Smith Andrea B Director | Award | 509 | — | Form 4 |
| Apr 28, 2026 | Riley Wayne Joseph Director | Award | 509 | — | Form 4 |
| Apr 28, 2026 | MICHELSON MICHAEL W Director | Award | 925 | — | Form 4 |
| Apr 28, 2026 | Johnston Hugh F Director | Award | 809 | — | Form 4 |
| Apr 28, 2026 | DEPARLE NANCY ANN Director | Award | 509 | — | Form 4 |
| Apr 28, 2026 | CHIDSEY JOHN Director | Award | 809 | — | Form 4 |
| Feb 13, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Option | 5,000 | $1.18M⚡ | Form 4 |
| Feb 13, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Other | 3,306 | $1.79M⚡ | Form 4 |
| Feb 18, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Sale | 1,694 | $904K | Form 4 |
| Feb 10, 2026 | Wyatt Christopher F. SVP & Controller | Award | 3,350 | — | Form 4 |
| Feb 10, 2026 | Wyatt Christopher F. SVP & Controller | Other | 1,034 | $519K | Form 4 |
| Feb 11, 2026 | Wyatt Christopher F. SVP & Controller | Sale | 4,000 | $2.02M⚡ | Form 4 |
| Feb 10, 2026 | Rossitto Erica SVP & Chief Nurse Executive | Award | 1,676 | — | Form 4 |
| Feb 10, 2026 | Rossitto Erica SVP & Chief Nurse Executive | Other | 418 | $210K | Form 4 |
| Feb 10, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Award | 8,372 | — | Form 4 |
| Feb 10, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Other | 3,006 | $1.51M⚡ | Form 4 |
| Feb 10, 2026 | Marks Mike A EVP and CFO | Award | 5,026 | — | Form 4 |
| Feb 10, 2026 | Marks Mike A EVP and CFO | Other | 1,690 | $848K | Form 4 |
| Feb 10, 2026 | HAZEN SAMUEL N CEO · Director | Award | 54,934 | — | Form 4 |
| Feb 10, 2026 | HAZEN SAMUEL N CEO · Director | Other | 21,323 | $10.71M⚡ | Form 4 |
| Feb 10, 2026 | Foster Jon M EVP and COO | Award | 15,696 | — | Form 4 |
| Feb 10, 2026 | Foster Jon M EVP and COO | Other | 5,888 | $2.96M⚡ | Form 4 |
| Feb 10, 2026 | Cuffe Michael S. EVP and Chief Clinical Officer | Award | 9,628 | — | Form 4 |
McAlevey Michael R
EVP & Chief Legal & Admin Off.
日期
Feb 13
股数
5,000
均价
$236.61
总金额
$1.18M ⚡
McAlevey Michael R
EVP & Chief Legal & Admin Off.
日期
Feb 13
股数
3,306
均价
$540.29
总金额
$1.79M ⚡
McAlevey Michael R
EVP & Chief Legal & Admin Off.
日期
Feb 18
股数
1,694
均价
$533.37
总金额
$904K
McAlevey Michael R
EVP & Chief Legal & Admin Off.
日期
Feb 10
股数
3,006
均价
$502.05
总金额
$1.51M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HCA 内幕交易
HCA 内幕交易
HCA Healthcare, Inc.（HCA）内幕交易数据来源于公司内部人（包括HAZEN SAMUEL N (CEO · Director), McAlevey Michael R (EVP & Chief Legal & Admin Off.), Marks Mike A (EVP and CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。HCA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看HCA Healthcare, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
HCA 内幕交易 · 5个问题HCA Healthcare, Inc.（HCA）的内部人包括高管和董事，如HAZEN SAMUEL N (CEO · Director), McAlevey Michael R (EVP & Chief Legal & Admin Off.), Marks Mike A (EVP and CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026